Itonis Inc (ITNS) 0.0196 $ITNS
Itonis, Inc. to Profit From Transactional Revenues by Marketing Its Licensed MyECheck Mobile App to Marijuana Dispensary Market
Marketwire - Tue Apr 08, 12:27PM CDT
Itonis, Inc. (PINKSHEETS: ITNS) today announced its plans to market its MyECheck proprietary mobile app to the massively exploding marijuana dispensary market in order to facilitate cash-free point of sale transactions to gain transactional fee revenues.
Itonis, Inc. Developing Cannabinoid-Based "Cloud9" Product
Marketwire - Thu Apr 03, 8:31AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) today announced that it is in the final phase of its research and development of a cannabinoid-based product presently named "Cloud9(TM)."
COREwafer Industries Inc.'s Stock Volume Soars amid Lawsuits and Hidden Debt
ACCESSWIRE - Tue Apr 01, 9:02AM CDT
COREwafer Industries Inc.'s (OCTPINK: WAFR) share volume soared Mar. 31, with 92,841,276 shares changing hands, nearly double its three-month average volume of 47,097,800 shares.
Itonis, Inc. Joins the National Cannabis Industry Association to Advance Into the Medical Marijuana Products and Services Sector
Marketwire - Tue Apr 01, 8:03AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) today announced that it has joined the National Cannabis Industry Association (NCIA) as a member in a part of the Company's preparations to expand into the medical marijuana products and services sector. The Company is positioning itself for tremendous opportunities in this vibrant sector in unison with its recent app licensing agreement with MyECheck, Inc.
Itonis Inc. Signs Licensing Agreement with MyECheck Inc. for Medical Marijuana Point of Purchase App
ACCESSWIRE - Tue Apr 01, 12:45AM CDT
Itonis Inc. (OTC: ITNS) has signed a Licensing Agreement with MyECheck, Inc. that opens the gates for Itonis to possibly become a leading player in the blossoming medical marijuana industry. In the licensing agreement, Itonis will acquire a software license for MyECheck's patented mobile payment app that will facilitate point of purchase transactions for medical marijuana, gambling, and general retail sales. There is no expiration date on that license. The company believes there is a significant revenue opportunity in addressing the demand regarding medical marijuana and the point of sales from medical suppliers.
Itonis, Inc. OTCpink ITNS today announced that it has signed a Licensing Agreement with MyECheck,OTCpink MYEC
M2 - Fri Mar 28, 12:50PM CDT
March 28, 2014 Vancouver (321gostocks) -- Itonis, Inc. (PINKSHEETS: ITNS) today announced that it has signed a Licensing Agreement with MyECheck, Inc. for Itonis to acquire a software license for MyECheck's patented mobile payment app that will facilitate point of purchase transactions for medical marijuana, gambling, and general retail sales. There is no expiration date on that license.
Itonis, Inc. Signs App License Agreement With MyECheck, Inc. for Medical Marijuana Point of Purchase App
Marketwire - Fri Mar 28, 10:14AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) today announced that it has signed a Licensing Agreement with MyECheck, Inc. for Itonis to acquire a software license for MyECheck's patented mobile payment app that will facilitate point of purchase transactions for medical marijuana, gambling, and general retail sales. There is no expiration date on that license.
Itonis, Inc. Update on Company Direction With Emesyl and Licensing of App for Medical Marijuana Point of Purchase
Marketwire - Wed Mar 26, 10:29AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) today issued the following update to its shareholders:
Arotech Corporation Announces More than $2M in Orders; DirectView Holdings Plans to Open a Colorado Office
ACCESSWIRE - Tue Mar 25, 11:26PM CDT
Arotech Corporation (NASDAQ: ARTX) - For an in-depth report on Arotech Corporation follow: www.BullTrends.com/stockquote/ARTX
Itonis Pharmaceuticals Completed Evaluation of Emesyl Product to Take Next Step to Manufacturing
Marketwire - Wed Mar 19, 10:00AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) is pleased to announce that Charles Hensley, PhD., the inventor of the Zicam(R) cold remedy, and his team has completed their evaluation of the manufactured samples of Emesyl(TM), the company's over-the-counter homeopathic product for nausea relief.
Itonis, Inc. Signs LOI With MyECheck, Inc. for Licensing of App for Medical Marijuana Point of Purchase
Marketwire - Mon Mar 17, 2:29PM CDT
Itonis, Inc. (PINKSHEETS: ITNS) is pleased to announce that it has entered into a Letter of Intent with MyECheck, Inc. to acquire a software license for MyECheck's patented mobile payment app that will facilitate point of purchase transactions for medical marijuana, gambling, and general retail sales.
Itonis Pharmaceuticals Received Emesyl Samples for Evaluation
Marketwire - Fri Feb 28, 12:50PM CST
Itonis, Inc. (PINKSHEETS: ITNS) is pleased to announce that it has received and is currently evaluating samples of its Emesyl(TM) product from its manufacturer. Oasis Health Products, Inc. delivered two versions of the Emesyl(TM) anti-nausea formula which are currently being evaluating for tolerance.
Itonis Pharmaceuticals Appoints New Scientific Officer to Guide Clinical Process for Homeopathic Products
Marketwire - Mon Dec 09, 9:00AM CST
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce today the addition of Ernesto Barron to Dr. Hensley's product development team. Mr. Barron will serve as Itonis Phamaceuticals' Chief Scientific Officer and Director of Clinical Research.
Itonis Pharmaceuticals Completed Packaging Graphics for Its Emesyl Brand of Nausea Remedy
Marketwire - Wed Dec 04, 9:58AM CST
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce that the Company has completed packaging graphics for its Emesyl(TM) Nausea Remedy.
Itonis Pharmaceuticals to Conduct Case Study for Its Emesyl Brand of Nausea Remedy
Marketwire - Mon Dec 02, 9:00AM CST
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce that the Company will conduct a case study to confirm the efficacy of its Emesyl(TM) Nausea Remedy in a clinical setting.
Itonis Pharmaceuticals and Dr. Charles Hensley to Receive Delivery of First Production Batch of Emesyl(TM) Nausea Remedy
Marketwire - Mon Nov 25, 9:00AM CST
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are to receive first batch of Emesyl(TM) product, the Company's over-the-counter homeopathic product for the relief of nausea.
Itonis Pharmaceuticals and Dr. Charles Hensley Hitting Production Milestones for Protection of Emesyl(TM) Nausea Remedy
Marketwire - Mon Nov 18, 8:50AM CST
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to release their manufacturing update for Emesyl(TM), the Company's over-the-counter homeopathic product for the relief of nausea.
Itonis Pharmaceuticals to Trademark Emesyl Nausea Relief Remedy
Marketwire - Thu Oct 24, 9:30AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce that the Company has applied to the USPTO to trademark its Emesyl brand for its homeopathic pharmaceutical nausea relief remedy. The Company's application has been assigned Serial No. 86099093.
Itonis Pharmaceuticals and Charles Hensley, Ph.D. to Begin Distributing Emesyl(TM) Anti-Nausea Homeopathic Product in Mexico
Marketwire - Thu Sep 12, 7:30AM CDT
Itonis, Inc.'s pharmaceutical division (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) Cold Remedy, are pleased to announce that Hensley Brothers Distribution, LLC ("HBD"
will distribute Emesyl((TM)), the Company's over-the-counter homeopathic product for nausea relief, to Mexico through one of HBD's distribution partners.
Itonis Pharmaceuticals, Led by Dr. Charles Hensley, the Inventor of Zicam(R) Cold Remedy, Received FDA Labeler Status
Marketwire - Wed Jul 31, 8:02AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce that the Company has received its labeler's code from the federal Food and Drug Administration (FDA).
Itonis, Inc. to Profit From Transactional Revenues by Marketing Its Licensed MyECheck Mobile App to Marijuana Dispensary Market
Marketwire - Tue Apr 08, 12:27PM CDT
Itonis, Inc. (PINKSHEETS: ITNS) today announced its plans to market its MyECheck proprietary mobile app to the massively exploding marijuana dispensary market in order to facilitate cash-free point of sale transactions to gain transactional fee revenues.
Itonis, Inc. Developing Cannabinoid-Based "Cloud9" Product
Marketwire - Thu Apr 03, 8:31AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) today announced that it is in the final phase of its research and development of a cannabinoid-based product presently named "Cloud9(TM)."
COREwafer Industries Inc.'s Stock Volume Soars amid Lawsuits and Hidden Debt
ACCESSWIRE - Tue Apr 01, 9:02AM CDT
COREwafer Industries Inc.'s (OCTPINK: WAFR) share volume soared Mar. 31, with 92,841,276 shares changing hands, nearly double its three-month average volume of 47,097,800 shares.
Itonis, Inc. Joins the National Cannabis Industry Association to Advance Into the Medical Marijuana Products and Services Sector
Marketwire - Tue Apr 01, 8:03AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) today announced that it has joined the National Cannabis Industry Association (NCIA) as a member in a part of the Company's preparations to expand into the medical marijuana products and services sector. The Company is positioning itself for tremendous opportunities in this vibrant sector in unison with its recent app licensing agreement with MyECheck, Inc.
Itonis Inc. Signs Licensing Agreement with MyECheck Inc. for Medical Marijuana Point of Purchase App
ACCESSWIRE - Tue Apr 01, 12:45AM CDT
Itonis Inc. (OTC: ITNS) has signed a Licensing Agreement with MyECheck, Inc. that opens the gates for Itonis to possibly become a leading player in the blossoming medical marijuana industry. In the licensing agreement, Itonis will acquire a software license for MyECheck's patented mobile payment app that will facilitate point of purchase transactions for medical marijuana, gambling, and general retail sales. There is no expiration date on that license. The company believes there is a significant revenue opportunity in addressing the demand regarding medical marijuana and the point of sales from medical suppliers.
Itonis, Inc. OTCpink ITNS today announced that it has signed a Licensing Agreement with MyECheck,OTCpink MYEC
M2 - Fri Mar 28, 12:50PM CDT
March 28, 2014 Vancouver (321gostocks) -- Itonis, Inc. (PINKSHEETS: ITNS) today announced that it has signed a Licensing Agreement with MyECheck, Inc. for Itonis to acquire a software license for MyECheck's patented mobile payment app that will facilitate point of purchase transactions for medical marijuana, gambling, and general retail sales. There is no expiration date on that license.
Itonis, Inc. Signs App License Agreement With MyECheck, Inc. for Medical Marijuana Point of Purchase App
Marketwire - Fri Mar 28, 10:14AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) today announced that it has signed a Licensing Agreement with MyECheck, Inc. for Itonis to acquire a software license for MyECheck's patented mobile payment app that will facilitate point of purchase transactions for medical marijuana, gambling, and general retail sales. There is no expiration date on that license.
Itonis, Inc. Update on Company Direction With Emesyl and Licensing of App for Medical Marijuana Point of Purchase
Marketwire - Wed Mar 26, 10:29AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) today issued the following update to its shareholders:
Arotech Corporation Announces More than $2M in Orders; DirectView Holdings Plans to Open a Colorado Office
ACCESSWIRE - Tue Mar 25, 11:26PM CDT
Arotech Corporation (NASDAQ: ARTX) - For an in-depth report on Arotech Corporation follow: www.BullTrends.com/stockquote/ARTX
Itonis Pharmaceuticals Completed Evaluation of Emesyl Product to Take Next Step to Manufacturing
Marketwire - Wed Mar 19, 10:00AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) is pleased to announce that Charles Hensley, PhD., the inventor of the Zicam(R) cold remedy, and his team has completed their evaluation of the manufactured samples of Emesyl(TM), the company's over-the-counter homeopathic product for nausea relief.
Itonis, Inc. Signs LOI With MyECheck, Inc. for Licensing of App for Medical Marijuana Point of Purchase
Marketwire - Mon Mar 17, 2:29PM CDT
Itonis, Inc. (PINKSHEETS: ITNS) is pleased to announce that it has entered into a Letter of Intent with MyECheck, Inc. to acquire a software license for MyECheck's patented mobile payment app that will facilitate point of purchase transactions for medical marijuana, gambling, and general retail sales.
Itonis Pharmaceuticals Received Emesyl Samples for Evaluation
Marketwire - Fri Feb 28, 12:50PM CST
Itonis, Inc. (PINKSHEETS: ITNS) is pleased to announce that it has received and is currently evaluating samples of its Emesyl(TM) product from its manufacturer. Oasis Health Products, Inc. delivered two versions of the Emesyl(TM) anti-nausea formula which are currently being evaluating for tolerance.
Itonis Pharmaceuticals Appoints New Scientific Officer to Guide Clinical Process for Homeopathic Products
Marketwire - Mon Dec 09, 9:00AM CST
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce today the addition of Ernesto Barron to Dr. Hensley's product development team. Mr. Barron will serve as Itonis Phamaceuticals' Chief Scientific Officer and Director of Clinical Research.
Itonis Pharmaceuticals Completed Packaging Graphics for Its Emesyl Brand of Nausea Remedy
Marketwire - Wed Dec 04, 9:58AM CST
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce that the Company has completed packaging graphics for its Emesyl(TM) Nausea Remedy.
Itonis Pharmaceuticals to Conduct Case Study for Its Emesyl Brand of Nausea Remedy
Marketwire - Mon Dec 02, 9:00AM CST
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce that the Company will conduct a case study to confirm the efficacy of its Emesyl(TM) Nausea Remedy in a clinical setting.
Itonis Pharmaceuticals and Dr. Charles Hensley to Receive Delivery of First Production Batch of Emesyl(TM) Nausea Remedy
Marketwire - Mon Nov 25, 9:00AM CST
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are to receive first batch of Emesyl(TM) product, the Company's over-the-counter homeopathic product for the relief of nausea.
Itonis Pharmaceuticals and Dr. Charles Hensley Hitting Production Milestones for Protection of Emesyl(TM) Nausea Remedy
Marketwire - Mon Nov 18, 8:50AM CST
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to release their manufacturing update for Emesyl(TM), the Company's over-the-counter homeopathic product for the relief of nausea.
Itonis Pharmaceuticals to Trademark Emesyl Nausea Relief Remedy
Marketwire - Thu Oct 24, 9:30AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce that the Company has applied to the USPTO to trademark its Emesyl brand for its homeopathic pharmaceutical nausea relief remedy. The Company's application has been assigned Serial No. 86099093.
Itonis Pharmaceuticals and Charles Hensley, Ph.D. to Begin Distributing Emesyl(TM) Anti-Nausea Homeopathic Product in Mexico
Marketwire - Thu Sep 12, 7:30AM CDT
Itonis, Inc.'s pharmaceutical division (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) Cold Remedy, are pleased to announce that Hensley Brothers Distribution, LLC ("HBD"
will distribute Emesyl((TM)), the Company's over-the-counter homeopathic product for nausea relief, to Mexico through one of HBD's distribution partners. Itonis Pharmaceuticals, Led by Dr. Charles Hensley, the Inventor of Zicam(R) Cold Remedy, Received FDA Labeler Status
Marketwire - Wed Jul 31, 8:02AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce that the Company has received its labeler's code from the federal Food and Drug Administration (FDA).
